Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Should Health Insurance (HIIQ) Stock Be In Your Portfolio?

Published 08/11/2016, 11:27 PM
Updated 07/09/2023, 06:31 AM
GNW
-
PRI
-
SLF
-
BFYT
-

On Aug 12, Zacks Investment Research upgraded Health Insurance Innovations, Inc. (NASDAQ:HIIQ) to a Zacks Rank #1 (Strong Buy).

Why the Upgrade?

Health Insurance has been witnessing upward revisions in earnings estimates on the back of its strong second-quarter 2016 results and raised guidance. This life insurer reported earnings of 27 cents per share in the second quarter, with a massive positive earnings surprise of 350%. Earnings soared 237.5% year over year on solid premium equivalents. With respect to earnings surprise, the company delivered positive surprise in each of the last four quarters.

Revenues surged 95.6% year over year on higher policies in force and continued strong sales.

Health Insurance continues to boost the sales results of the individual and family finance business or IFPs, which are short-term medical and limited medical policies. The company reported 0.3 million policies in force at the end of the second quarter, up 128% year over year.

The company strengthened its balance sheet through solid operational performance. Cash balance at end of the quarter was 60% higher than the 2015-end level. Total assets also jumped 17.6% from the 2015-end level.

Agile Health Insurance (a short-term medical insurance provider), which is Health Insurance’s largest distributor, sold approximately 16,000 STM policies and a record 2,500 supplemental dental and vision policies in the quarter. The company expects Agile Health Insurance to add new products this year. This will ensure future growth prospects for the company.

Based on strong performance, Health Insurance now expects adjusted earnings per share to be between 55 cents and 65 cents and revenues in the range of $155–$165 million. This is higher than earnings of 38–42 cents per share and revenues of $138–144 million guided earlier. The new guidance accounts for a 104–141% increase in earnings and 48–58% rise in the top line.

The Zacks Consensus Estimate for 2016 moved up 46.5% to 63 cents per share as all the estimates were revised higher over the last 30 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

HEALTH INS INN Price and Consensus

HEALTH INS INN Price and Consensus | HEALTH INS INN Quote

Stocks to Consider

Investors interested in the life insurance industry can look for Genworth Financial, Inc. (NYSE:GNW) , Primerica, Inc. (NYSE:PRI) and Sun Life Financial Inc. (TO:SLF) . While Genworth Financial sports a Zacks Rank #1 (Strong Buy), both Primerica and Sun Life Financial hold a Zacks Rank #2 (Buy).



PRIMERICA INC (PRI): Free Stock Analysis Report

SUN LIFE FINL (SLF): Free Stock Analysis Report

GENWORTH FINL (GNW): Free Stock Analysis Report

HEALTH INS INN (HIIQ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.